Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (534)	5/22/2004 6:11:54 PM
From: ~digs	Read Replies (1) \| Respond to of 7944

NAWL.ob @ .025 daily stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!Ul14!Uk14]&pref=G weekly stockcharts.com[w,a]waclyiay[pc40!c200!f][vc60][iut!Ul14!Uk14]&pref=G NatureWell, Inc. is engaged primarily in the research and development of proprietary healthcare products intended for a variety of conditions and has completed development of a homeopathic over-the-counter (OTC) drug used for the treatment and prevention of migraine headaches. The Company's MigraSpray aims to provide fast relief from migraines and other types of headaches without side effects. This homeopathic herbal preparation is designed to be a convenient, economical and fast-acting sublingual spray. NatureWell has also completed development of AllerSpray, which provides relief of allergy symptoms without drowsiness, dry-mouth or other side effects.